Generate a tailored SOP for Dr. Arthur Liesz. Improve your application with a focused, well-structured draft.
Arthur Liesz is a principal investigator with over a decade of experience researching the brain-immune interaction in acute brain injuries. His scientific goal is to make new discoveries that lead to therapies benefiting stroke patients. He has pioneered work in understanding the neuroprotective role of regulatory T cells in stroke and has successfully reproduced key findings on the bi-directional link between the brain and gut microbiota-related immune mechanisms in acute brain injury. He has contributed to clinical research on blocking leukocyte invasion into the brain, leading to completed clinical Phase II studies. Liesz is known for his innovative research ideas that focus on translational relevance, with key achievements including elucidating the relationship between sterile inflammation and remote organ dysfunction as a result of stroke. His lab integrates cutting-edge methodologies to explore the complexities of immune responses post-stroke, with ongoing projects related to trained immunity and neuroinflammation.
Liesz Lab, Ludwig Maximilians University Munich • Munich, Germany
Leading research on brain-immune interactions and developing novel therapeutic approaches for stroke patients.
Department of Economics. Includes an admissions test in Munich if the GPA is not better than 2.50 or equivalence is unclear.